VFA
SGNT

Virtus Fund Advisers’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Virtus Fund Advisers’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,867
Closed -$48K – 2517
2014
Q2 		$48K Buy
+1,867
New +$41.5K ﹤0.01% 1904

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Virtus Fund Advisers's SGNT Position: Q3 2014 in Review

Virtus Fund Advisers sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2014, closing a stake of 1,867 shares — an estimated $48K sold.

Virtus Fund Advisers first reported a position in SGNT in Q2 2014 and held it in 1 quarter. The position peaked at $48K in Q2 2014. 114 funds tracked by Wall St. Rank hold SGNT as of Q3 2014.

  • Virtus Fund Advisers reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,867 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $48K.
  • Virtus Fund Advisers first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $48K in Q2 2014.
  • 114 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.